Marcio Moreira

Marcio Moreira

Federal University of Sao Paulo (UNIFESP), Brazil

Title: The combination of rhytidoplasty and fractional CO2 laser therapy in the treatment of facial aging


Dr. Marcio Moreira has completed his Ph.D at the age of 42 years from São Paulo Federal University School of Medicine. He is the director of Plasticlínica and professor of plastic and reconstructive surgery on School of Medicine at Inga University / UNINGÁ - Maringa - PR - Brazil. He is a Full Member of the Brazilian Society of Plastic Surgery (SBCP) and of the International Society of Aesthetic Plastic Surgery (ISAPS). He has published numerous papers in reputed journals and serving as an editorial board member of repute.


Background: The facial aging is a natural biological process noticed by falling tissue, accenting lines, furrows, winkles, dyschromias and loss of facial volume. The rhytidectomy alone often fail to achieve patients expected goal. That's why there is a high demand for adjunct laser skin treatment.
Material and Methods: From January 2007 to February 2013, 80 treat patients skin types I to IV Fitzpatrick were underwent to large undermined cutaneous flap rhytidectomy and SMAS plicature plus hialuronic acid injection on nasolabial folds and lips and concomitant Lumenis UltraPulse CO2 Active FX total ablation mode resurfacing on non undermined skin and fractional laser of skin on the undermined skin utilizing different energizes concerning type of skin. The patients were evaluated at 5º, 10º, 15º, 30º, 60º and at 90º days answers to a specific questionnaire about satisfaction.
Results: Complications included expansive haemathoms 5%, partial necrosis 1,25%, bacterial infection 1,25%, herpetic infection 1,25%, hypertrophic scar 1,25%, spot hyperchromic 1,25%. 95% of patients declared extremely satisfied; 3,75% satisfied and only 1,25% unsatisfied.
Conclusion: The combination of subcutaneous flap rhytidectomy and SMAS plicature with fractional laser resurfacing plus hyaluronic acid injection is a safe procedure with low incidence of major complications and improves patient satisfaction.
Level of Evidence: IV - Case series with pre/post test